Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918104 | Radiotherapy and Oncology | 2015 | 7 Pages |
Abstract
The differences in the late G2+ GU/GI risk cannot be explained by the differences in treatment modalities themselves, but by the total radiation dose to the GU/GI tract, which had a causal role in the development of late G2+ GU/GI toxicity across all treatment modality groups.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shinya Sutani, Toshio Ohashi, Masanori Sakayori, Tomoya Kaneda, Shoji Yamashita, Tetsuo Momma, Takashi Hanada, Yutaka Shiraishi, Junichi Fukada, Mototsugu Oya, Naoyuki Shigematsu,